Workflow
Imunon(IMNN)
icon
Search documents
Imunon(IMNN) - 2019 Q3 - Quarterly Report
2019-11-14 21:23
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 001-15911 CELSION CORPORATION (Exact name of Registrant as specified in its charter) (State or ot ...
Imunon(IMNN) - 2019 Q2 - Earnings Call Transcript
2019-08-15 22:05
Celsion Corporation (CLSN) Q2 2019 Earnings Conference Call August 15, 2019 11:00 AM ET Company Participants Kim Golodetz - LHA Michael Tardugno - Chairman, President & CEO Jeffrey Church - CFO Conference Call Participants Hartaj Singh - Oppenheimer & Company Jason Kolbert - Dawson James Kumar Raja - Brookline Capital Markets Operator Good morning. My name is Travis and I will be your operator today. At this time, I would like to welcome you all to Celsion Second Quarter 2019 Financial Results Conference Ca ...
Imunon(IMNN) - 2019 Q2 - Quarterly Report
2019-08-14 21:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 001-15911 CELSION CORPORATION (Exact name of Registrant as specified in its charter) (State or other j ...
Imunon(IMNN) - 2019 Q1 - Earnings Call Transcript
2019-05-15 20:54
Celsion Corporation (CLSN) Q1 2019 Earnings Conference Call May 15, 2019 11:00 AM ET Company Participants Jeffrey Church - Chief Financial Officer Michael Tardugno - Chairman, President & Chief Executive Officer Khursheed Anwer - Chief Scientific Officer Conference Call Participants Justin Kim - Oppenheimer & Co. Kumar Raja - Brookline Capital Markets Matthew Cross - JonesTrading Barry Rubin - Arsenal Investments Operator Good morning. My name is Cathy and I'll be your operator today. At this time I would l ...
Imunon(IMNN) - 2019 Q1 - Quarterly Report
2019-05-15 12:51
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 001-15911 CELSION CORPORATION (Exact name of Registrant as specified in its charter) (State or other ...
Imunon(IMNN) - 2018 Q4 - Earnings Call Transcript
2019-03-29 18:51
Celsion Corporation (CLSN) Q4 2018 Earnings Conference Call March 29, 2019 11:00 AM ET Company Participants Jeffrey Church - CFO Michael Tardugno - CEO Nicholas Borys - CMO Conference Call Participants Kumar Raja - Brookline Capital Markets Justin Kim - Oppenheimer Matthew Cross - JonesTrading Operator Good morning. My name is Savanna, and I will be your operator today. At this time, I would like to welcome you all to Celsion's fourth quarter and full year 2018 financial results conference call. All lines h ...
Imunon(IMNN) - 2018 Q4 - Annual Report
2019-03-29 12:53
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-15911 CELSION CORPORATION (Exact Name of Registrant as Specified in Its Charter) DELAWARE 52-1256615 (State or Other Jurisdiction ...
Celsion Corporation (CLSN) To Present At Oppenheimer 29th Annual Healthcare Conference - Slideshow
2019-03-20 16:45
Corporate Presentation March 2019 Safe Harbor Statement This presentation and any statements made for and during any presentation or meeting contain forward‐looking statements related to Celsion Corporation ("Celsion") under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995 and are subject to risks and uncertainties that could cause actual results to differ materially from those projected. These statements may be identified by the use of forward‐looking words ...